Yuting Xiu

Tumor immune organoids support preclinical evaluation of cancer immunotherapies through comparative modelling and translational investigation

The response of cancer patients to immunotherapy varies significantly. However, there is still a lack of functional models that can accurately predict efficacy in vitro while preserving individual tumor immune characteristics of patients. This to some extent restricts the develop...